Director, Clinical Research, Pulmonary and Critical Medicine
Asthma Research Center/Brigham and Women’s Hospital
Dr. Elliot Israel is the Gloria and Anthony Simboli Distinguished Professor in Asthma Research and Professor of Medicine at Harvard Medical School and the Director of Clinical Research in the Pulmonary and Critical Care Division at the Brigham and Women’s Hospital in Boston. He directs the Brigham and Women’s Hospital Severe Asthma Program.
He received his medical degree from the Johns Hopkins University School of Medicine. He completed training in internal medicine at Johns Hopkins Hospital and Weill Cornell Medical Center at New York-Presbyterian Hospital (formerly New York Hospital). He undertook fellowships in pulmonary and critical care medicine and allergy and immunology at Harvard Medical School. He is board certified in allergy and immunology, pulmonary medicine, critical care medicine, and internal medicine.
Dr. Israel’s research interests include severe asthma, using precision medicine to optimize therapeutic interventions, pharmacogenetic influences on treatment responses, and the role of fatty acid metabolites in asthma pathobiology. He leads a USA federally-funded study to test novel interventions to narrow disparities in asthma outcomes. He is BWH principal investigator of a USA National Institutes of Health-funded initiative to advance precision medicine utilizing adaptive design techniques to identify novel treatments for severe asthma. He leads the protocol design committee of that initiative. He has authored over 200 peer-reviewed publications and is a member of the USA NAEPP Committee examining asthma guidelines. He is the recipient of the Harvard Medical School Daniel D. Federman Outstanding Clinical Educator Award.
Page last updated: March 9, 2020
A Breath of Fresh Air in Your Inbox
Want updates on the latest lung health news, including COVID-19 updates, research, inspiring stories and health information?
Join the 500,000+ people getting our newsletter!
Thank you! You've been successfully subscribed to our newsletter!